| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.04B | +12.2% |
| Cost of Revenue | $471.0M | +9.4% |
| R&D Expense | $137.7M | +8.6% |
| SG&A Expense | $89.8M | +10.6% |
| Operating Income | $261.6M | +24.6% |
| Pre-tax Income | $266.8M | +24.9% |
| Income Tax | $48.5M | +30.6% |
| Net Income | $218.4M | +23.7% |
| EPS (Basic) | $3.56 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $266.2M | -1.7% |
| Accounts Receivable | $205.5M | +13.4% |
| Current Assets | $503.3M | +5.0% |
| Total Assets | $757.6M | +12.5% |
| Current Liabilities | $400.3M | +9.4% |
| Stockholders' Equity | $299.1M | +7.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $295.0M | +19.8% |
| Capital Expenditures | $8.7M | +83.4% |
| Investing Cash Flow | -$8.7M | -83.4% |
| Financing Cash Flow | -$286.4M | -46.1% |
| Free Cash Flow | $286.3M | +18.6% |
| +24.5% |
| EPS (Diluted) | $3.51 | +24.5% |